Mild Hypothermia of 34°C Reduces Side Effects of Rt-PA Treatment After Thromboembolic Stroke in Rats

Overview

Journal Exp Transl Stroke Med

Publisher Biomed Central

Date 2012 Mar 9

PMID 22397464

Citations 12

Authors

Bernd Kallmunzer

Stefan Schwab

Rainer Kollmar

Affiliations

Soon will be listed here.

Abstract

Background: Hypothermia is neuroprotective in experimental stroke and may extend the so far limited therapeutic time window for thrombolysis. Therefore, hypothermia of 34°C and its effects on delayed thrombolysis including reperfusion-associated injury were investigated in a model of thromboembolic stroke (TE).

Methods: Male Wistar rats (n = 48) were subjected to TE. The following treatment groups were investigated: control group - normothermia (37°C); thrombolysis group - rt-PA 90 min after TE; hypothermia by 34°C applied 1.5 to 5 hours after TE; combination therapy- hypothermia and rt-PA. After 24 hours infarct size, brain edema and neuroscore were assessed. Protein markers for inflammation and adhesion, gelatinase activity, and blood brain barrier (BBB) disruption were determined. MRI-measurements investigated infarct evolution and blood flow parameters.

Results: The infarct volume and brain swelling were smaller in the hypothermia group compared to the other groups (p < 0.05 to p < 0.01). Thrombolysis resulted in larger infarct and brain swelling than all others. Hypothermia in combination with thrombolysis reduced these parameters compared to thrombolysis (p < 0.05). Moreover, the neuroscore improved in the hypothermia group compared to control and thrombolysis. Animals of the combination therapy performed better than after thrombolysis alone (p < 0.05). Lower serum concentration of sICAM-1, and TIMP-1 were shown for hypothermia and combination therapy. Gelatinase activity was decreased by hypothermia in both groups.

Conclusions: Therapeutic hypothermia reduced side-effects of rt-PA associated treatment and reperfusion in our model of TE.

Citing Articles

Therapeutic hypothermia is not dead, but hibernating!.

Freedman Jr R, Schock R, Peacock W Clin Exp Emerg Med. 2024; 11(3):238-242.

PMID: 39390630 PMC: 11467454. DOI: 10.15441/ceem.24.291.

A Systematic Review and Meta-Analysis of Therapeutic Hypothermia and Pharmacological Cotherapies in Animal Models of Ischemic Stroke.

Suerte A, Liddle L, Abrahart A, Khiabani E, Colbourne F Ther Hypothermia Temp Manag. 2024; 14(4):229-242.

PMID: 38946643 PMC: 11685787. DOI: 10.1089/ther.2024.0012.

The Modulatory Role of Hypothermia in Poststroke Brain Inflammation: Mechanisms and Clinical Implications.

Xu W, Geng X, Fayyaz A, Ding Y Cerebrovasc Dis. 2024; 53(6):776-788.

PMID: 38286123 PMC: 11633906. DOI: 10.1159/000536384.

Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence.

Zhang Z, Zhang L, Ding Y, Han Z, Ji X Aging Dis. 2018; 9(3):507-522.

PMID: 29896438 PMC: 5988605. DOI: 10.14336/AD.2017.0628.

Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy.

Sun M, Jin H, Sun X, Huang S, Zhang F, Guo Z Oxid Med Cell Longev. 2018; 2018:3804979.

PMID: 29770166 PMC: 5892600. DOI: 10.1155/2018/3804979.

References

Wang Y, Tsirka S, Strickland S, Stieg P, Soriano S, Lipton S . Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998; 4(2):228-31. DOI: 10.1038/nm0298-228. View

Shaw G, Bavani N, Dhamija A, Lindsell C . Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model. Thromb Res. 2005; 117(5):603-8. DOI: 10.1016/j.thromres.2005.05.005. View

Bernard S, Gray T, Buist M, Jones B, Silvester W, Gutteridge G . Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002; 346(8):557-63. DOI: 10.1056/NEJMoa003289. View

Mokhtarani M, Mahgoub A, Morioka N, Doufas A, Dae M, Shaughnessy T . Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg. 2001; 93(5):1233-9. DOI: 10.1097/00000539-200111000-00038. View

Burggraf D, Martens H, Jager G, Hamann G . Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb Haemost. 2003; 89(6):1072-80. View

Flavin M, Zhao G, Ho L . Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia. 2000; 29(4):347-54. View

Warach S, Latour L . Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004; 35(11 Suppl 1):2659-61. DOI: 10.1161/01.STR.0000144051.32131.09. View

van der Worp H, Sena E, Donnan G, Howells D, Macleod M . Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007; 130(Pt 12):3063-74. DOI: 10.1093/brain/awm083. View

Menzies S, Hoff J, Betz A . Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992; 31(1):100-6; discussion 106-7. DOI: 10.1227/00006123-199207000-00014. View

10.

Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V . Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci. 2002; 22(4):289-96. DOI: 10.1007/s10072-001-8170-y. View

11.

Tang X, Liu L, Yenari M . Combination therapy with hypothermia for treatment of cerebral ischemia. J Neurotrauma. 2009; 26(3):325-31. PMC: 2752358. DOI: 10.1089/neu.2008.0594. View

12.

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317-29. DOI: 10.1056/NEJMoa0804656. View

13.

Maier C, Ahern K, Cheng M, Lee J, Yenari M, Steinberg G . Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke. 1998; 29(10):2171-80. DOI: 10.1161/01.str.29.10.2171. View

14.

Heiland S, Benner T, Reith W, Forsting M, Sartor K . Perfusion-weighted MRI using gadobutrol as a contrast agent in a rat stroke model. J Magn Reson Imaging. 1997; 7(6):1109-15. DOI: 10.1002/jmri.1880070625. View

15.

Vogel J, Mobius C, Kuschinsky W . Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke. 1999; 30(5):1134-41. DOI: 10.1161/01.str.30.5.1134. View

16.

. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25(5):457-507. DOI: 10.1159/000131083. View

17.

Kollmar R, Henninger N, Bardutzky J, Schellinger P, Schabitz W, Schwab S . Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study. Exp Neurol. 2004; 190(1):204-12. DOI: 10.1016/j.expneurol.2004.07.006. View

18.

Pan J, Konstas A, Bateman B, Ortolano G, Pile-Spellman J . Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology. 2006; 49(2):93-102. PMC: 1786189. DOI: 10.1007/s00234-006-0183-z. View

19.

BUSCH E, Kruger K, Hossmann K . Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res. 1998; 778(1):16-24. DOI: 10.1016/s0006-8993(97)01008-1. View

20.

Hashimoto M, Zhao L, Nowak Jr T . Temporal thresholds for infarction and hypothermic protection in Long-Evans rats: factors affecting apparent 'reperfusion injury' after transient focal ischemia. Stroke. 2008; 39(2):421-6. DOI: 10.1161/STROKEAHA.107.495788. View